22 October 2013 - Deborah Wilkes
Germany’s Stada Arzneimittel has demonstrated its OTC ambitions by striking two deals in quick succession. The news that Stada was set to acquire the Aqualor brand in Russia for €131 million came soon after the generics firm paid €259 million for the UK’s Thornton & Ross.
This NEWS EXTRA publication from OTCToolbox is designed to give you an insight into Stada's current thinking.
Almost 2,000 words long, this 10-page NEWS EXTRA provides details of Stada's recent OTC acquisitions, outlines the company's business strategy and details the financial performance.
RAPID INSIGHTS MADE EASY
AVAILABLE TO DOWNLOAD IMMEDIATELY
AS A PDF
See Payment Options box on this page
This NEWS EXTRA is also available as part of an Annual Subscription to the OTCToolbox website (click here to find out more).
For alternative payment options and delivery methods, or other questions, please send an email to enquiries@otctoolbox.com.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.